{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:45:28Z","timestamp":1759963528141},"reference-count":28,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2004,8,12]],"date-time":"2004-08-12T00:00:00Z","timestamp":1092268800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The <jats:italic>in vitro<\/jats:italic> interactions of caspofungin (CSP) with terbinafine (TRB) and ravuconazole (RVC) with 5\u2010fluorocytosine (5\u2010FC) were tested against 82 clinical and environmental isolates of <jats:italic>Cryptococcus neoformans<\/jats:italic> from China. The interaction of CSP with TRB proved synergistic against those isolates with a CSP MIC \u22642\u2003<jats:italic>\u03bc<\/jats:italic>g\u2003ml<jats:sup>\u22121<\/jats:sup> (5% of the isolates), additive against 42% of the isolates and indifferent against 53%. The effects of RVC with 5\u2010FC were synergistic, additive or indifferent against 8%, 26% and 67% of the isolates, respectively. No antagonistic effects were found among any of the drugs. The combinations of CSP with TRB and RVC with 5\u2010FC may display beneficial effects in a strain\u2010dependent manner, while in no case showed antagonistic effects. These data might be of use to design safer and more efficient treatments for patients with cryptococcosis and warrant further evaluation.<\/jats:p>","DOI":"10.1111\/j.1439-0507.2004.00998.x","type":"journal-article","created":{"date-parts":[[2004,8,12]],"date-time":"2004-08-12T10:31:24Z","timestamp":1092306684000},"page":"319-325","source":"Crossref","is-referenced-by-count":7,"title":["Effects of several antifungal drug combinations against clinical and environmental isolates of <i>Cryptococcus neoformans<\/i> from China"],"prefix":"10.1111","volume":"47","author":[{"given":"Li\u2010Ping","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Gil\u2010Lamaignere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank\u2010Michael C.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,8,12]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2002.00725.x"},{"key":"e_1_2_9_3_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/oxfordjournals.epirev.a036195","article-title":"Emergence of cryptococcal disease: epidemiologic perspectives 100\u2003years after its discovery","volume":"17","author":"Hajjeh RA","year":"1995","journal-title":"Epidemiol Rev"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004310051047"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/313757"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.1999.00475.x"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907193010303"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-2-234"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/517056"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.4.812"},{"key":"e_1_2_9_11_2","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts","author":"National Committee for Clinical Laboratory Standards","year":"1997"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.8.1691"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.30.11.2881-2886.1992"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.1.245-247.2002"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000239603"},{"key":"e_1_2_9_16_2","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/JCM.36.10.2874-2876.1998","article-title":"Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients","volume":"36","author":"Jessup CJ","year":"1998","journal-title":"J Clin Microbiol"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/42.2.217"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.5.815"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/375080"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/317614"},{"key":"e_1_2_9_21_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.41.2.331","article-title":"Pneumocandin L\u2010743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro","volume":"41","author":"Franzot SP","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.9.3039-3041.2002"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1882-1885.2001"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.5.1057"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1999.tb00026.x"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-002-0877-z"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.40.5.529.534"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/515042"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2883-2886.2000"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.2004.00998.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.2004.00998.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T18:51:24Z","timestamp":1696963884000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2004.00998.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.1439-0507.2004.00998.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.2004.00998.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}